TDOC

TELADOC HEALTH, INC.

TDOC · CIK 1477449 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$2.5B
20182025
Net Income−$0.2B
20182025
Operating CF$0.3B
20182025
Free Cash Flow$0.3B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$2.5B$2.6B$2.6B$2.4B———$0.1B
Cost of Revenue———$0.7B$0.7B$0.4B$0.1B$0.0B
Gross Profit———————$0.1B
R&D Expense$0.3B$0.3B$0.3B$0.3B$0.3B$0.2B$0.0B$0.0B
SG&A Expense————————
Operating Income$-0.3B$-1.0B$-0.2B$-13.7B$-0.3B$-0.5B$-0.0B$-0.0B
Net Income$-0.2B$-1.0B$-0.2B$-13.7B$-0.4B$-0.5B$-0.0B$-0.0B
EPS (Basic)$-1.14$-5.87$-1.34$-84.60$-2.73———
EPS (Diluted)$-1.14$-5.87$-1.34$-84.60$-2.73———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$2.9B$3.5B$4.4B$4.3B$17.7B$17.8B$1.6B$1.5B
Current Assets$1.1B$1.7B$1.5B$1.3B$1.2B$1.1B$0.6B$0.5B
Cash & Equivalents$0.8B$1.3B$1.1B$0.9B$0.9B$0.7B$0.5B$0.4B
Total Liabilities$1.5B$2.0B——————
Current Liabilities$0.4B$0.9B$0.4B$0.4B$0.3B$0.3B$0.1B$0.1B
Stockholders' Equity$1.4B$1.5B$2.3B$2.3B$16.0B$15.9B$1.0B$1.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.3B$0.3B$0.4B$0.2B$0.2B$-0.1B$0.0B$-0.0B
Investing Cash Flow$-0.3B$-0.1B$-0.2B$-0.2B$-0.1B$-0.6B$0.0B$-0.3B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.6B$0.0B$0.0B$0.0B$0.0B$0.9B$0.0B$0.6B
← Companies